Top Market Shifts Transforming the Interventional Oncology Devices Market Landscape: Key Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Interventional Oncology Devices Market Through 2025?
The market for interventional oncology devices has experienced consistent growth in the past few years. The market size is expected to increase from $2.39 billion in 2024 to $2.5 billion in 2025, with a compound annual growth rate (CAGR) of 4.4%. The expansion during the historic period is due to factors such as an aging population, rising incidence of cancer, growing pharmaceutical R&D spending, higher healthcare expenditure and the proliferation of healthcare facilities.

What's the Projected Size of the Global Interventional Oncology Devices Market by 2029?
The market for interventional oncology devices is predicted to experience robust growth in the coming years, reaching a value of $3.28 billion in 2029 with a compound annual growth rate (CAGR) of 7.0%. This expansion during the forecast period can be associated with a rise in the aging population, an increased preference for minimally invasive surgeries (MIS), higher research and development expenditures, an increase in healthcare spending, significant potential in developing economies, and a growing incidence of cancer and chronic diseases. Key trends for the forecast period are geared towards the development of advanced image-guided oncology devices, leveraging AI in creating innovative devices, developing groundbreaking embolic devices for enhanced oncology procedures, an emphasis on the utilization of robotics technology, and fostering partnerships with other businesses and research institutes for accelerated product development and innovation.

View the full report here:
https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Top Growth Drivers in the Interventional Oncology Devices Industry: What's Accelerating the Market?
Prominent firms in the interventional oncology devices market are channeling their efforts towards technologies like tissue volume to increase both diagnostic precision and treatment success in oncology procedures. The term tissue volume denotes the quantity of biological tissue secured during a biopsy procedure. Larger amounts of tissue generally results in a more inclusive sample, bolstering the precision of diagnosis and efficiency of devising a treatment plan. For example, Argon Medical, a medical device firm based in the US, introduced the SuperCore Advantage semi-automatic biopsy in June 2023. The SuperCore Advantage has the capability to gather up to 35% more samples compared to its top competitors, thus reducing the necessity for multiple biopsy passes. This characteristic is crucial in securing substantial tissue samples for precise diagnosis.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Interventional Oncology Devices Market?
Leading corporations are increasingly adopting robotics in interventional oncology tools to enhance effectiveness. The robotic framework amalgamates the elements of image-assisted planning and navigation with the precise placement of various implements within the body, improving overall accuracy and efficiency. Illustratively, Quantum Surgical's Epione interventional oncology robotics platform received approval from the U.S. Food and Drug Administration in March 2022.

What Are the Main Segments in the Interventional Oncology Devices Market?
The interventional oncology devices market covered in this report is segmented -

1) By Product: Embolization Devices, Ablation Devices, Support Devices
2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization
3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types

Subsegments:
1) By Embolization Devices: Embolic Agents, Catheters For Embolization, Delivery Systems For Embolic Agents
2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Laser Ablation Devices
3) By Support Devices: Imaging Guidance Systems, Access Devices, Fluid Management Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3304&type=smp

Which Top Companies are Driving Growth in the Interventional Oncology Devices Market?
Major companies operating in the interventional oncology devices market include Boston Scientific Corporation, Terumo Corporation, Siemens Healthineers, Sirtex Medical Limited, Henlius, Viant Medical, AngioDynamics Inc., Pfizer, Steris Applied Sterilization Technologies, Dr.Reddys, CapeRay, Innovent Biologics, Novartis AG, Consonance, ABLbio, Adimmune, Heraeus Medical, Bioavlee, Mediceena International, Sinapi biomedical, Olympus, Freudenberg Medical, Hisun Pharma, Beijing ShuangLu Pharmaceuticals, Edwards LifeSciences Corp, Gulf Dent Trading, LifeTech Scientific Corporation, Biomerics, Medtronic plc, Dickinson & Company, 3M Company, DISA Vascular, Johnson & Johnson, Eurolab, Koninklijke Philips, Quantum SurgicalKyowa Hakko Kirin, Viatris, Nipro, Zimmer Biomet Holdings, Profound Medical, Gedeon Richter, Baxter, Ti-TaMED, Abbott Laboratories, Cook Medical LLC, Adavium Medical, Autocam Medical, Bio-Thera, Stryker, GE Healthcare, Sonic Healthcare, Medicem, HealthTronics, Bayer AG, Intuitive Surgical Inc, Aster DM Healthcare, Danaher Corporation, Varian Medical Systems Inc., Smileneo, EDAP TMS S.A, Fresenius Medical Care AG, China Regenerative Medicine International

Which Regions Will Dominate the Interventional Oncology Devices Market Through 2029?
North America was the largest region in the interventional oncology devices market in 2024. Asia-Pacific was the second largest region in the global interventional oncology devices market report. The regions covered in the interventional oncology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3304

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.